Global B-Cell Non-Hodgkin's Lymphoma Drug Market Growth (Status and Outlook) 2022-2028
- LP 4886092
- 102 Pages
- March 2022
- Pharmaceuticals
The United States B-Cell Non-Hodgkin's Lymphoma Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global B-Cell Non-Hodgkin's Lymphoma Drug market, reaching US$ million by the year 2028. As for the Europe B-Cell Non-Hodgkin's Lymphoma Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main B-Cell Non-Hodgkin's Lymphoma Drug players cover Roche, Gilead Sciences, TG Therapeutics, and Bayer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of B-Cell Non-Hodgkin's Lymphoma Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Oral
Injection
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Retail Pharmacy
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
Gilead Sciences
TG Therapeutics
Bayer
Secura Bio
Epizyme
Eisai
Acrotech Biopharma
Teva
Eagle Pharmaceuticals
MundiPharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2017-2028
2.1.2 B-Cell Non-Hodgkin's Lymphoma Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 B-Cell Non-Hodgkin's Lymphoma Drug Segment by Type
2.2.1 Oral
2.2.2 Injection
2.3 B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type
2.3.1 B-Cell Non-Hodgkin's Lymphoma Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type (2017-2022)
2.4 B-Cell Non-Hodgkin's Lymphoma Drug Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application
2.5.1 B-Cell Non-Hodgkin's Lymphoma Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Application (2017-2022)
3 B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Player
3.1 B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Players
3.1.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Players (2020-2022)
3.1.2 Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Players (2020-2022)
3.2 Global B-Cell Non-Hodgkin's Lymphoma Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 B-Cell Non-Hodgkin's Lymphoma Drug by Regions
4.1 B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Regions (2017-2022)
4.2 Americas B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth (2017-2022)
4.3 APAC B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth (2017-2022)
4.4 Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2017-2022)
5.2 Americas B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2017-2022)
5.3 Americas B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region (2017-2022)
6.2 APAC B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2017-2022)
6.3 APAC B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe B-Cell Non-Hodgkin's Lymphoma Drug by Country (2017-2022)
7.2 Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2017-2022)
7.3 Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug by Region (2017-2022)
8.2 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Forecast by Regions (2023-2028)
10.1.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Forecast by Regions (2023-2028)
10.1.2 Americas B-Cell Non-Hodgkin's Lymphoma Drug Forecast
10.1.3 APAC B-Cell Non-Hodgkin's Lymphoma Drug Forecast
10.1.4 Europe B-Cell Non-Hodgkin's Lymphoma Drug Forecast
10.1.5 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Forecast
10.2 Americas B-Cell Non-Hodgkin's Lymphoma Drug Forecast by Country (2023-2028)
10.2.1 United States B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.2.2 Canada B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.2.3 Mexico B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.2.4 Brazil B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.3 APAC B-Cell Non-Hodgkin's Lymphoma Drug Forecast by Region (2023-2028)
10.3.1 China B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.3.2 Japan B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.3.3 Korea B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.3.4 Southeast Asia B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.3.5 India B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.3.6 Australia B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.4 Europe B-Cell Non-Hodgkin's Lymphoma Drug Forecast by Country (2023-2028)
10.4.1 Germany B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.4.2 France B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.4.3 UK B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.4.4 Italy B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.4.5 Russia B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.5 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Forecast by Region (2023-2028)
10.5.1 Egypt B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.5.2 South Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.5.3 Israel B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.5.4 Turkey B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.5.5 GCC Countries B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast
10.6 Global B-Cell Non-Hodgkin's Lymphoma Drug Forecast by Type (2023-2028)
10.7 Global B-Cell Non-Hodgkin's Lymphoma Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
11.1.3 Roche B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
11.2.3 Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 TG Therapeutics
11.3.1 TG Therapeutics Company Information
11.3.2 TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
11.3.3 TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 TG Therapeutics Main Business Overview
11.3.5 TG Therapeutics Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
11.4.3 Bayer B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Secura Bio
11.5.1 Secura Bio Company Information
11.5.2 Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
11.5.3 Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Secura Bio Main Business Overview
11.5.5 Secura Bio Latest Developments
11.6 Epizyme
11.6.1 Epizyme Company Information
11.6.2 Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
11.6.3 Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Epizyme Main Business Overview
11.6.5 Epizyme Latest Developments
11.7 Eisai
11.7.1 Eisai Company Information
11.7.2 Eisai B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
11.7.3 Eisai B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Eisai Main Business Overview
11.7.5 Eisai Latest Developments
11.8 Acrotech Biopharma
11.8.1 Acrotech Biopharma Company Information
11.8.2 Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
11.8.3 Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Acrotech Biopharma Main Business Overview
11.8.5 Acrotech Biopharma Latest Developments
11.9 Teva
11.9.1 Teva Company Information
11.9.2 Teva B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
11.9.3 Teva B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Teva Main Business Overview
11.9.5 Teva Latest Developments
11.10 Eagle Pharmaceuticals
11.10.1 Eagle Pharmaceuticals Company Information
11.10.2 Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
11.10.3 Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Eagle Pharmaceuticals Main Business Overview
11.10.5 Eagle Pharmaceuticals Latest Developments
11.11 MundiPharma
11.11.1 MundiPharma Company Information
11.11.2 MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
11.11.3 MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 MundiPharma Main Business Overview
11.11.5 MundiPharma Latest Developments
12 Research Findings and Conclusion
Table 1. B-Cell Non-Hodgkin's Lymphoma Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injection
Table 4. B-Cell Non-Hodgkin's Lymphoma Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type (2017-2022)
Table 7. B-Cell Non-Hodgkin's Lymphoma Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Application (2017-2022)
Table 10. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Player (2020-2022)
Table 12. B-Cell Non-Hodgkin's Lymphoma Drug Key Players Head office and Products Offered
Table 13. B-Cell Non-Hodgkin's Lymphoma Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Regions (2017-2022)
Table 18. Americas B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Country (2017-2022)
Table 20. Americas B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type (2017-2022)
Table 22. Americas B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Application (2017-2022)
Table 24. APAC B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Region (2017-2022)
Table 26. APAC B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type (2017-2022)
Table 28. APAC B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Application (2017-2022)
Table 30. Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Country (2017-2022)
Table 32. Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type (2017-2022)
Table 34. Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of B-Cell Non-Hodgkin's Lymphoma Drug
Table 43. Key Market Challenges & Risks of B-Cell Non-Hodgkin's Lymphoma Drug
Table 44. Key Industry Trends of B-Cell Non-Hodgkin's Lymphoma Drug
Table 45. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share Forecast by Application (2023-2028)
Table 51. Roche Details, Company Type, B-Cell Non-Hodgkin's Lymphoma Drug Area Served and Its Competitors
Table 52. Roche B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
Table 53. Roche B-Cell Non-Hodgkin's Lymphoma Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Roche Main Business
Table 55. Roche Latest Developments
Table 56. Gilead Sciences Details, Company Type, B-Cell Non-Hodgkin's Lymphoma Drug Area Served and Its Competitors
Table 57. Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
Table 58. Gilead Sciences Main Business
Table 59. Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Gilead Sciences Latest Developments
Table 61. TG Therapeutics Details, Company Type, B-Cell Non-Hodgkin's Lymphoma Drug Area Served and Its Competitors
Table 62. TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
Table 63. TG Therapeutics Main Business
Table 64. TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. TG Therapeutics Latest Developments
Table 66. Bayer Details, Company Type, B-Cell Non-Hodgkin's Lymphoma Drug Area Served and Its Competitors
Table 67. Bayer B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
Table 68. Bayer Main Business
Table 69. Bayer B-Cell Non-Hodgkin's Lymphoma Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Bayer Latest Developments
Table 71. Secura Bio Details, Company Type, B-Cell Non-Hodgkin's Lymphoma Drug Area Served and Its Competitors
Table 72. Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
Table 73. Secura Bio Main Business
Table 74. Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Secura Bio Latest Developments
Table 76. Epizyme Details, Company Type, B-Cell Non-Hodgkin's Lymphoma Drug Area Served and Its Competitors
Table 77. Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
Table 78. Epizyme Main Business
Table 79. Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Epizyme Latest Developments
Table 81. Eisai Details, Company Type, B-Cell Non-Hodgkin's Lymphoma Drug Area Served and Its Competitors
Table 82. Eisai B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
Table 83. Eisai Main Business
Table 84. Eisai B-Cell Non-Hodgkin's Lymphoma Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Eisai Latest Developments
Table 86. Acrotech Biopharma Details, Company Type, B-Cell Non-Hodgkin's Lymphoma Drug Area Served and Its Competitors
Table 87. Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
Table 88. Acrotech Biopharma Main Business
Table 89. Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Acrotech Biopharma Latest Developments
Table 91. Teva Details, Company Type, B-Cell Non-Hodgkin's Lymphoma Drug Area Served and Its Competitors
Table 92. Teva B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
Table 93. Teva Main Business
Table 94. Teva B-Cell Non-Hodgkin's Lymphoma Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Teva Latest Developments
Table 96. Eagle Pharmaceuticals Details, Company Type, B-Cell Non-Hodgkin's Lymphoma Drug Area Served and Its Competitors
Table 97. Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
Table 98. Eagle Pharmaceuticals Main Business
Table 99. Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Eagle Pharmaceuticals Latest Developments
Table 101. MundiPharma Details, Company Type, B-Cell Non-Hodgkin's Lymphoma Drug Area Served and Its Competitors
Table 102. MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Product Offered
Table 103. MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. MundiPharma Main Business
Table 105. MundiPharma Latest Developments
List of Figures
Figure 1. B-Cell Non-Hodgkin's Lymphoma Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type in 2021
Figure 7. B-Cell Non-Hodgkin's Lymphoma Drug in Hospital
Figure 8. Global B-Cell Non-Hodgkin's Lymphoma Drug Market: Hospital (2017-2022) & ($ Millions)
Figure 9. B-Cell Non-Hodgkin's Lymphoma Drug in Retail Pharmacy
Figure 10. Global B-Cell Non-Hodgkin's Lymphoma Drug Market: Retail Pharmacy (2017-2022) & ($ Millions)
Figure 11. B-Cell Non-Hodgkin's Lymphoma Drug in Other
Figure 12. Global B-Cell Non-Hodgkin's Lymphoma Drug Market: Other (2017-2022) & ($ Millions)
Figure 13. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Application in 2021
Figure 14. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Player in 2021
Figure 15. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Regions (2017-2022)
Figure 16. Americas B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2017-2022 ($ Millions)
Figure 17. APAC B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2017-2022 ($ Millions)
Figure 18. Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2017-2022 ($ Millions)
Figure 20. Americas B-Cell Non-Hodgkin's Lymphoma Drug Value Market Share by Country in 2021
Figure 21. Americas B-Cell Non-Hodgkin's Lymphoma Drug Consumption Market Share by Type in 2021
Figure 22. Americas B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Application in 2021
Figure 23. United States B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Region in 2021
Figure 28. APAC B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Application in 2021
Figure 29. China B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. India B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Country in 2021
Figure 36. Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type in 2021
Figure 37. Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Application in 2021
Figure 38. Germany B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. France B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Application in 2021
Figure 46. Egypt B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country B-Cell Non-Hodgkin's Lymphoma Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 52. APAC B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 53. Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 55. United States B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 56. Canada B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 57. Mexico B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 58. Brazil B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 59. China B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 60. Japan B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 61. Korea B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 63. India B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 64. Australia B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 65. Germany B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 66. France B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 67. UK B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 68. Italy B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 69. Russia B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 70. Spain B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 71. Egypt B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 72. South Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 73. Israel B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 74. Turkey B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries B-Cell Non-Hodgkin's Lymphoma Drug Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
